WHAT THE CEREDA GROUP IS ALL ABOUT
The group has created a functional genomics platform aimed specifically at studying the molecular aspects of rare diseases that affect the metabolism and nervous system of children from birth.
The platform integrates genomics, transcriptomics, metabolomics, lipidomics analysis methodologies with bioinformatic pepilins, advanced computational methods for data analysis.
Most recently, the group is involved in multidisciplinary collaborative initiatives aimed at developing advanced therapies for precision medicine.
The group led by Prof. Cereda can offer comprehensive support for the analyses needed to study the genome and epigenome through methodologies such as: exome/genome sequencing, DNA methylation (methylome), transcript analysis (transcriptomics), and metabolomics.
Already The group also provides bioinformatics and computational pipelines for the analysis of omics and the study of their relationship.


WHAT SERVICES WE OFFER
Omics platforms are accessible to research groups and hospitals in the Lombardy Region Health System for the application of diagnostic methodologies in the neonatal and pediatric fields on whole genome sequencing.
In addition, it is possible to have third-party bioinformatic and computational analyses on web-found omics data with an approach also of integration between the various omics.
The platform’s tools and expertise will also be available for the execution of basic research projects in the field of rare diseases.